Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26203/fullpdf
Reference25 articles.
1. 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostate carcinoma;Dattoli;Int J Radiat Oncol Biol Phys.,1997
2. Brachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-up;Ragde;Semin Surg Oncol.,1997
3. Prostate brachytherapy: treatment strategies;Stone;J Urol.,1999
4. A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019;Lee;Int J Radiat Oncol Biol Phys.,2006
5. Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019;Lee;Cancer.,2007
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of Prostate Cancer-related Genitourinary Radiation Injury on Mental Health Diagnosis and Treatment: Assessment of 55,425 Men;Urology;2024-01
2. The Effect of Maximum Tumor Diameter by MRI on Disease Control in Intermediate and High-risk Prostate Cancer Patients Treated With Brachytherapy Boost;Clinical Genitourinary Cancer;2022-02
3. Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/0526);International Journal of Radiation Oncology*Biology*Physics;2021-11
4. Five‐year outcomes from a prospective comparative effectiveness study evaluating external‐beam radiotherapy with or without low‐dose‐rate brachytherapy boost for localized prostate cancer;Cancer;2021-02-17
5. Low-Dose-Rate Brachytherapy Combined With Ultrahypofractionated Radiation Therapy for Clinically Localized, Intermediate-Risk Prostate Cancer: Results From a Prospective Trial;International Journal of Radiation Oncology*Biology*Physics;2020-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3